mPDEV for Dermatology Clinics in Vancouver
Ships to dermatology and aesthetic medicine clinics in Vancouver, Greater Vancouver, and across British Columbia. Five-criteria evaluation framework, batch-specific Certificate of Analysis, MISEV2023-aligned characterization, and cold-chain shipping (2–3 business days from Ottawa). Direct from the Ottawa manufacturer — no distributor margin.
How to evaluate an exosome skincare product for your clinic
Five criteria separate a characterized EV preparation from a label that uses the word "exosome" without backing it. None are optional. A defensible product answers all five.
- 01
Source and biogenesis
Confirm the EV source — plant, mammalian stem cell, platelet, or other — and that biogenesis (not just size) was demonstrated. Marker panel must include EV-associated proteins (CD9, CD63, CD81, TSG101, Alix where applicable) and the absence of contaminants.
- 02
Particle concentration
Concentration must be reported per mL on a batch-specific basis, measured by an orthogonal method (Nanoparticle Tracking Analysis is the field standard). Claims without a measured value belong in marketing copy, not a Certificate of Analysis.
- 03
Certificate of Analysis
Every shipment ships with a batch-specific CoA covering particle concentration, characterization method, marker panel, and contamination screen. Generic product sheets are not CoAs.
- 04
Isolation method and the biomolecular corona
Isolation method changes what is in the vial. Harsh methods strip the biomolecular corona; gentler methods preserve it. The corona is part of the active ingredient. Ask which isolation route the manufacturer uses and why.
- 05
Cold-chain integrity
EV preparations are biologically active and temperature-sensitive. Verify cold-chain handling from manufacturer to clinic, including transit excursion logging where the formulation requires it.
The long-form version of this framework, with source literature and worked examples, lives at How to evaluate an EV or exosome product before stocking it.
How to order mPDEV for your clinic
Direct from BioThera's Ottawa facility to verified Canadian dermatology and aesthetic medicine practices. No distributor layer. Each shipment ships with its batch-specific Certificate of Analysis.
Step 1
Verify credentials
BioThera ships mPDEV directly to verified dermatology and aesthetic medicine practices. Submit your clinic credentials (regulatory license number, ordering physician, shipping address) through the contact form.
Step 2
Request a batch-specific CoA
Receive the active batch CoA before ordering. The CoA reports NTA particle concentration, EV marker panel, contamination screen, and MISEV2023 characterization disclosures.
Step 3
Confirm cold-chain logistics
Shipments leave Ottawa with cold-chain packaging suited to the destination. Confirm delivery windows, signature-on-receipt requirements, and storage conditions on intake.
Step 4
Place your initial order
Initial orders are sized to a single treatment cycle. Repeat orders run on a clinic-specific cadence agreed with the BioThera team. Pricing is disclosed to verified clinics; volume discounts apply.
Shipping mPDEV to Vancouver clinics
Origin
Ottawa, Ontario
Shipped directly from the BioThera Solutions facility. No distributor handoff.
Transit
2–3 business days from Ottawa
Cold-chain packaging sized to the destination. Signature on receipt available on request.
Quality
Batch-specific CoA
Every shipment includes the Certificate of Analysis for the batch in the box. MISEV2023 disclosures available on request.
Frédéric St-Denis-Bissonnette, PhD
Founder & CEO, BioThera Solutions. Named contributor, MISEV2023.
The evaluation framework on this page is the same one used inside BioThera's own characterization workflow. It is published openly so that clinicians can hold every EV product — including ours — to the same standard.
Request a Certificate of Analysis
Clinics receive the active batch CoA before ordering. Pricing is disclosed to verified clinics.